This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
I have a patient who tried several antidepressants and had poor results – what are the chances of improvement using BrainsWay Deep TMS Therapy?
BrainsWay Deep TMS is effective for a wide range of depression patients, including severe, treatment resistant depression cases. The FDA has cleared BrainsWay Deep TMS therapy for treating patients with depression, who tried 1-4 of antidepressants with no improvement.
BrainsWay is also indicated by the FDA as an intended adjunct treatment for adult patients suffering from Obsessive Compulsive Disorder (OCD)/FDA De Novo.